Accessibility Tools
Invert colors
Monochrome
Dark contrast
Light contrast
Low saturation
High saturation
Highlight links
Highlight headings
Screen reader
Read mode
Content scaling
100
%
Font size
100
%
Line height
100
%
Letter spacing
100
%
(678) 384-7220
info@geovax.com
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact
SEC Filings
Group by
None
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Search:
Clear filters
Year
All
2018
2019
2020
2021
2022
2023
2024
2025
Description
All
8-K
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Annual Report
Current Report
General Statement of Acquisition of Beneficial Ownership
Initial Ownership Report
Notice of Effectiveness
Other Definitive Proxy Statements
Other Preliminary Proxy Statement
Post-Effective amendments for registration status
Preliminary Proxy Soliciting Materials
Prospectus
Prospectus Supplement
Quarterly Report
Registration Statement
Statement of Changes in Beneficial Ownership
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
(1)
No records
View
01-22
(1)
No records
2019
01-22
Current Report
8-K
View
02-19
(1)
No records
2019
02-19
8-K
Current Report
View
02-26
(1)
No records
2019
02-26
Current Report
8-K
View
02-27
(1)
No records
2019
02-27
Preliminary Proxy Soliciting Materials
PRER14A
View
03-01
(1)
No records
2019
03-01
Other Definitive Proxy Statements
DEF 14A
View
03-14
(1)
No records
2019
03-14
Other Definitive Proxy Statements
DEF 14A
View
03-26
(1)
No records
2019
03-26
Annual Report
10-K
View
03-27
(1)
No records
2019
03-27
Current Report
8-K
View
03-29
(1)
No records
2018
03-29
General Statement of Acquisition of Beneficial Ownership
SC 13D/A
View
About GeoVax
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Our Technology
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Product Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Investors
Corporate Profile
News
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Phone
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact
Search